← Back to Search

Image-Guided Programming for Cochlear Implants

N/A
Waitlist Available
Led By Jack H. Noble, PhD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults aged 18 to 90 years that have undergone diagnostic testing for sensorineural hearing loss and have received a cochlear implant with asymptotic improvement in performance with SOC programming will be considered eligible for the study.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 1 post cochlear implant activation
Awards & highlights

Study Summary

This trial is testing a new way to map cochlear implants, which are devices surgically implanted to help people with hearing impairments. The new method uses information from CT scans to deactivate electrodes that aren't positioned well.

Who is the study for?
This trial is for adults aged 18 to 90 with sensorineural hearing loss who have received a cochlear implant and seen limited improvement. Candidates must speak English due to the test battery used. Pregnant individuals or those outside the age range are excluded.Check my eligibility
What is being tested?
The study tests 'Image-guided Cochlear Implant Programming' (IGCIP), which uses post-op CT scans to map out where cochlear implant electrodes sit in relation to the neural interface, potentially improving hearing by deactivating poorly positioned electrodes.See study design
What are the potential side effects?
While not explicitly stated, side effects may include discomfort from additional CT scans and potential auditory changes due to electrode deactivation as part of IGCIP.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 90 years old, have sensorineural hearing loss, and received a cochlear implant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 1 post cochlear implant activation
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 1 post cochlear implant activation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
AzBio Sentence Scores at +5 Signal to Noise Ratio (SNR)
Secondary outcome measures
Minimum Speech Test Battery

Trial Design

1Treatment groups
Experimental Treatment
Group I: Image-guided Cochlear Implant Programming (IGCIP)Experimental Treatment1 Intervention
Cochlear implant programming using IGCIP.

Find a Location

Who is running the clinical trial?

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
325 Previous Clinical Trials
178,010 Total Patients Enrolled
Vanderbilt University Medical CenterLead Sponsor
850 Previous Clinical Trials
668,977 Total Patients Enrolled
Rene H. Gifford, PhDStudy ChairVanderbilt University Medical Center

Media Library

Cochlear Implant Surgery Clinical Trial Eligibility Overview. Trial Name: NCT03306082 — N/A
Cochlear Implants Research Study Groups: Image-guided Cochlear Implant Programming (IGCIP)
Cochlear Implants Clinical Trial 2023: Cochlear Implant Surgery Highlights & Side Effects. Trial Name: NCT03306082 — N/A
Cochlear Implant Surgery 2023 Treatment Timeline for Medical Study. Trial Name: NCT03306082 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for individuals to join this clinical trial at the present time?

"Data on clinicaltrials.gov reveals that this particular investigation is not presently registering patients - it was initially posted in June of 2015 and last amended in November 2022. However, 15 other medical trials are currently seeking candidates."

Answered by AI

What are the requirements to partake in this experiment?

"This research project seeks 150 patients aged 18-90 that have undergone testing for sensorineural hearing loss and been successfully implanted with cochlear devices. To qualify, the patient must also demonstrate symptom reduction following implantation optimization through SOC programming."

Answered by AI

Is the age criterion for this clinical trial limited to those aged 70 or younger?

"This clinical trial adheres to a set of inclusion criteria, which stipulate that all participants must be at least 18 years old and not exceed 90."

Answered by AI
~18 spots leftby May 2025